Geron Corporation
Head Quarters
Suite 2070 149 Commonwealth Drive USWebsite
http://www.geron.comIndustry
BiotechnologyEmployees
17Exchange
NASDAQGeron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 9 |
| Gross Margin (%) | 0.00% |
| Net Margin (%) | -1.40% |
| Returns | Stock |
| Sales | $5.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$7.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 0.00 |
| EPS | $0.00 |